URBANA – The University of Illinois’ COVID-19 testing process has received Emergency Use Authorization from the federal Food and Drug Administration. Authorization was granted in a February 24 letter to the university from FDA Chief Scientist, Rear Admiral Denise M. Hinton. Ben Taylor, spokesman for Shield Illinois, the U of I’s program for marketing
URBANA – The University of Illinois at Urbana-Champaign’s saliva-based COVID-19 test has never operated under emergency use authorization from the U.S. Food and Drug Administration, despite prior claims that it did, an FDA spokesperson tells Illinois Newsroom. Since July, the U of I has used a COVID-19 test it developed to test all students and
EDITOR’S NOTE, Sept. 29: This story is no longer up-to-date, as University of Illinois officials claimed the campus’ saliva-based test had received FDA emergency use authorization on Aug. 19, but an FDA spokesperson tells Illinois Newsroom the test has never operated under an EUA. For more information on the newly learned details, click here. CHAMPAIGN